Skip to main content
Equibles
AMRN logo

AMRN · Amarin Corp Plc\Uk · Metrics

Track AMRN — free

Use AMRN with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$14.39 +0.14 (+0.98%)
Rebalance outlook locked
Market Cap
$290.12M
Shares
21.12M

AMRN metrics

64 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$14.25
Market cap
$290.12M

Price action

20 metrics
Price change (1W)
-2.4%
Price change (30D)
-3.4%
Price change (3M)
-2.2%
Price change (6M)
-3.1%
Price change (YTD)
-2.4%
Price change (1Y)
-9.3%
Trailing year
Price change (5Y)
—
52-week high
$20.25
52-week low
$13.50
Change from 52-week high
-32.7%
Change from 52-week low
+1.0%
Annualized volatility
44.1%
Annualized volatility (3M)
27.0%
Beta
0.5
RSI (14D)
38.7
Price vs SMA 50
-5.2%
Price vs SMA 200
-7.6%
Avg volume (3M)
80,455
Relative volume
1.0
Average dollar volume
$1.18M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - General
Shares outstanding
21.12M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
1.6×
reciprocal yield 64.2%
P / book
0.7
reciprocal yield 152.9%
FCF yield
—
TTM · current market cap
Buyback yield
0.3%
P / FCF
—
P / operating cash flow
18.6
reciprocal yield 5.4%
Earnings yield
-9.3%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.3%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
42.0%
Operating margin
-21.9%
Trailing 12 months
Net margin
-14.6%
Gross profit (TTM)
$78.13M
Operating profit (TTM)
−$40.77M
Net income (TTM)
−$27.12M
Trailing 12 months
Diluted EPS (TTM)
$-0.07
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.06

Growth

11 metrics
Revenue growth YoY
-42.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$186.23M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+0.5%
Year over year · more shares
Revenue CAGR (3Y)
-16.7%
Revenue CAGR (5Y)
-19.0%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-6.1%
Return on assets
-4.3%
Debt / equity
—
Current ratio
3.7
EBITDA (TTM)
−$79.25M
Free cash flow (TTM)
—
Quick ratio
2.7
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$143.56M
Total assets
$624.36M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$15.57M
Capital expenditures (TTM)
$252,000
R&D (TTM)
$19.02M
SG&A (TTM)
$83.06M
Stock compensation (TTM)
$8.00M
R&D / revenue
10.2%
Stock compensation / revenue
4.3%

Ownership (13F)

3 metrics
13F filers
81
13F filer change QoQ
+12
Institutional ownership
22.4%

Short interest

3 metrics
Short interest
2.5%
Latest settlement · 10.8 days to cover
Days to cover
10.8d
Short-squeeze score
52 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 897448 CUSIP 023111404 13F (30d) 47 filings 47 filers Visit website Investor relations